Drugmakers to cooperate in safety review of diabetes drugs (Reuters, 12 June 2013)

19 Jun 2013


Pharmaceutical companies producing GLP-1 receptor agonists and DPP-4 inhibitors have announced their plans for participation in new and ongoing safety reviews of said drugs.

Full article


Share this story